- Home
- GOVX vs TRIB Comparison
GOVX vs TRIB Comparison
Compare GOVX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- TRIB
- Stock Information
- Founded
- GOVX 2001
- TRIB 1992
- Country
- GOVX United States
- TRIB Ireland
- Employees
- GOVX N/A
- TRIB N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GOVX Health Care
- TRIB Health Care
- Exchange
- GOVX Nasdaq
- TRIB Nasdaq
- Market Cap
- GOVX 23.8M
- TRIB 24.0M
- IPO Year
- GOVX N/A
- TRIB N/A
- Fundamental
- Price
- GOVX $2.26
- TRIB $0.81
- Analyst Decision
- GOVX Strong Buy
- TRIB
- Analyst Count
- GOVX 5
- TRIB 0
- Target Price
- GOVX $14.20
- TRIB N/A
- AVG Volume (30 Days)
- GOVX 715.7K
- TRIB 147.6K
- Earning Date
- GOVX 11-12-2024
- TRIB 11-15-2024
- Dividend Yield
- GOVX N/A
- TRIB N/A
- EPS Growth
- GOVX N/A
- TRIB N/A
- EPS
- GOVX N/A
- TRIB N/A
- Revenue
- GOVX $3,090,161.00
- TRIB $59,126,000.00
- Revenue This Year
- GOVX N/A
- TRIB $11.63
- Revenue Next Year
- GOVX $150.51
- TRIB $10.13
- P/E Ratio
- GOVX N/A
- TRIB N/A
- Revenue Growth
- GOVX N/A
- TRIB N/A
- 52 Week Low
- GOVX $1.09
- TRIB $0.75
- 52 Week High
- GOVX $11.18
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- GOVX 44.80
- TRIB 25.82
- Support Level
- GOVX $2.17
- TRIB $0.75
- Resistance Level
- GOVX $2.50
- TRIB $0.93
- Average True Range (ATR)
- GOVX 0.17
- TRIB 0.11
- MACD
- GOVX -0.04
- TRIB 0.00
- Stochastic Oscillator
- GOVX 18.33
- TRIB 13.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.